Forepont Capital Partners

We nurture the Bio&Med Tech champions of tomorrow.

#enablersofhealthinnovation #nurturingtheeconomyoftomorrow

[Forepont Capital Partners @ForepontP]

The present and future of #BCI (Brain-computer interface) technology is bright and impactful for patients around the world.

Tom from Synchron and Michael from Precision Neuroscience trailblazing in DCA with the gov and FDA alongside other leaders in the field

[Forepont Capital Partners @ForepontP]

The Neurogen Foundation and our 10/10 program are the heart and passion of Forepont Capital Partners. We donate 10% of our net revenues and of our time to the #foundation and sponsor deep medical #research. Click here to learn more about the foundation: https://t.co/Cki3dNYa8n

[Forepont Capital Partners @ForepontP]

Since 2014, we at Forepont believe in #empowering the entrepreneur's vision in order to enhance their potentiel and make a lasting #positiveimpact.

Discover our new presentation film below.

[Forepont Capital Partners @ForepontP]

We are delighted to launch today the new version of our website https://t.co/2wqYFrpT7U. From our portfolio of #startups to the presentation of our 10/10 program through the Neurogen Foundation, this new site will allow you to know everything about FPC. #BioTech #MedTech

[Forepont Capital Partners @ForepontP]

We are convinced that French territories are home to future international champions of #innovation. We are proud to have invested in @BioSpeedia and @ReLyfe, two leaders based in Saint-Etienne and Reims https://t.co/2FpFEDS501
@PerdriauGael @CCILYONMETRO @ARS_ARA_SANTE

[Forepont Capital Partners @ForepontP]

Since 2014, we have been working to execute a coherent and global investment strategy. With our investments in @BBridgeDigital, @relyfe_ai, and Synchron, we are strengthening the potential and coherence of our portfolio in #biotechs #medtech and #neurotech https://t.co/dD9VoIHfTT

[Forepont Capital Partners @ForepontP]

Today, we are delighted to be part of the @Synchron adventure. Thanks to this #investment, the leader in implantable #braincomputer interfaces will benefit of our international network for optimal development in Europe and France more particularly. https://t.co/uuysicXDZC

[Forepont Capital Partners @ForepontP]

We are delighted to see that France has been chosen to open the doors of the #WHO HealthAcademy in 2023. France's expertise in #healthcare training and #biotechnology must shine on an international scale!
https://t.co/245YukQ4h4

[Forepont Capital Partners @ForepontP]

We are delighted to participate in the birth of Relyfe, a Franco-American group pioneering #medical #AI for the prevention and prediction of real-life chronic diseases. Discover the story of this operation which illustrates our #investment philosophy https://t.co/lhpWy8VPId

[Forepont Capital Partners @ForepontP]

"It's not just about financial capital. It's also about human development." In addition to financial support, we provide operational, logistical, and scientific help to our #startups. Come and discover our philosophy in this article from @bymaddyness
https://t.co/QsZsZaLMzu

[Forepont Capital Partners @ForepontP]

"In France, we have good researchers and a good network of #biotechs and #startups, but industry funding is not sufficient, so industrialization is not happening on the territory."
The French talent pool exists. Let's support it!
https://t.co/aAow4e7Lfl

[Forepont Capital Partners @ForepontP]

To support French & US biotechs and medtechs, let's give ourselves the means to remove the obstacles to their development.
Thanks to @LesEchos for this article on FCP's $130 million #fundraising dedicated to French & US start-ups in the #healthtech sector
https://t.co/oN5lDRX22Q

[Forepont Capital Partners @ForepontP]

Since Monday, it is possible to buy Covid-19 self-tests in in France. Our portfolio champion @SpeediaBio is considered as one of the most efficient on the market.

Congrats @SpeediaBio for this major #innovation in the #healthcare sector!

https://t.co/9ArF0cdyGW

[Forepont Capital Partners @ForepontP]

Getting French #healthcare startups off the ground is the key objective of the "HealthTech Plan".

This resonates with our mission : we support the financing of #biotechs and #medtechs and we help founders building processes and ecosystems to grow faster.
https://t.co/CiUONzzNtQ